161 related articles for article (PubMed ID: 10827162)
1. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation.
Belli LS; Zavaglia C; Alberti AB; Poli F; Rondinara G; Silini E; Taioli E; de Carlis L; Scalamogna M; Forti D; Pinzello G; Idèo G
Hepatology; 2000 Jun; 31(6):1345-50. PubMed ID: 10827162
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.
Belli LS; Burra P; Poli F; Battista Alberti A; Silini E; Zavaglia C; Fagiuoli S; Prando D; Espadas de Arias A; Boninsegna S; Tinelli C; Scalamogna M; de Carlis L; Pinzello G
Gastroenterology; 2006 Mar; 130(3):695-702. PubMed ID: 16530511
[TBL] [Abstract][Full Text] [Related]
3. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
4. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.
Kuzushita N; Hayashi N; Moribe T; Katayama K; Kanto T; Nakatani S; Kaneshige T; Tatsumi T; Ito A; Mochizuki K; Sasaki Y; Kasahara A; Hori M
Hepatology; 1998 Jan; 27(1):240-4. PubMed ID: 9425943
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease.
Hüe S; Cacoub P; Renou C; Halfon P; Thibault V; Charlotte F; Picon M; Rifflet H; Piette JC; Pol S; Caillat-Zucman S
J Infect Dis; 2002 Jul; 186(1):106-9. PubMed ID: 12089669
[TBL] [Abstract][Full Text] [Related]
6. HLA class II genes determine the natural variance of hepatitis C viral load.
Fanning LJ; Levis J; Kenny-Walsh E; Whelton M; O'Sullivan K; Shanahan F
Hepatology; 2001 Jan; 33(1):224-30. PubMed ID: 11124840
[TBL] [Abstract][Full Text] [Related]
7. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
[TBL] [Abstract][Full Text] [Related]
9. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
10. Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population.
Fanning LJ; Levis J; Kenny-Walsh E; Wynne F; Whelton M; Shanahan F
Hepatology; 2000 Jun; 31(6):1334-7. PubMed ID: 10827160
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
[TBL] [Abstract][Full Text] [Related]
12. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
13. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
[TBL] [Abstract][Full Text] [Related]
14. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
15. Natural history of recurrent hepatitis C.
Berenguer M
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S14-8. PubMed ID: 12362293
[TBL] [Abstract][Full Text] [Related]
16. Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with hepatitis C virus infection.
López-Vázquez A; Rodrigo L; Miña-Blanco A; Martínez-Borra J; Fuentes D; Rodríguez M; Pérez R; González S; López-Larrea C
J Infect Dis; 2004 Mar; 189(6):957-63. PubMed ID: 14999597
[TBL] [Abstract][Full Text] [Related]
17. Host and donor risk factors before and after liver transplantation that impact HCV recurrence.
Berenguer M
Liver Transpl; 2003 Nov; 9(11):S44-7. PubMed ID: 14586894
[TBL] [Abstract][Full Text] [Related]
18. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
[TBL] [Abstract][Full Text] [Related]
19. Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation.
Cotler SJ; Gaur LK; Gretch DR; Wile M; Strong DM; Bronner MP; Carithers RL; Emond MJ; Perkins JD; Nelson KA
Tissue Antigens; 1998 Nov; 52(5):435-43. PubMed ID: 9864033
[TBL] [Abstract][Full Text] [Related]
20. Association between HLA class II antigens and hepatitis C virus infection.
Scotto G; Fazio V; D'Alessandro G; Monno L; Saracino A; Palumbo E; Angarano G
J Biol Regul Homeost Agents; 2003; 17(4):316-21. PubMed ID: 15065760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
